Head & Neck Trials

B9991016

B9991016 – A randomized double-blind phase 3 study of Avelumab in combination with standard of care chemo-radiotherapy (Cisplatin plus definitive radiation therapy) versus standard of care chemo-radiotherapy in the front-line neck treatment of patients with locally advanced squamous cell carcinoma of the head and neck.

What type of cancer? What stage?
1. Head and neck cancer.
Who is eligible?
1. First line treatment.
How will I be treated?
1. All patients get definitive treatment. Patients may also get Avelumab (immunotherapy).

For physicians: more information about this specific trial at clinicaltrials.gov.

Related locations